Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Pre-Market Outlook

Pre-Market Outlook

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Ratings
  • Markets
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Price Target
  • Small Cap
  • Trading Ideas

PDS Biotechnology To Rally Around 129%? Here Are 5 Other Price Target Changes For Tuesday

By Lisa Levin
November 15, 8:26 AM
Chardan Capital raised PDS Biotechnology Corporation (NASDAQ:PDSB) price target from $15 to $16. . Chardan Capital analyst Geulah…

AKTS

Read More
1 minute read
  • Analyst Ratings
  • Markets
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Price Target
  • Small Cap

Intellia Therapeutics To Rally Around 143%? Plus Stifel Cuts PT On This Stock By 94%

By Lisa Levin
November 15, 7:53 AM
  Chardan Capital boosted the price target on Intellia Therapeutics, Inc. (NASDAQ: NTLA) from $121 to $129. Intellia Therapeutics shares fell 3% to close at $53.30 on Monday.

CMBM

Read More
3 minute read
  • Earnings
  • Economics
  • Federal Reserve
  • Futures
  • Markets
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Previews
  • Top Stories
  • Trading Ideas

Nasdaq, S&P 500 Futures Skyrocket After Tamer PPI Data That Confirms Slowing Inflation, Walmart’s Beat-And-Raise Q3

By Shanthi Rexaline
November 15, 6:39 AM
The index futures are solidly higher in premarket trading on Tuesday, as stocks strive to return to winning ways amid lingering hopes of a Fed pause.

AAP

Read More
1 minute read
  • Earnings
  • Markets
  • News
  • Pre-Market Outlook
  • Trading Ideas

Investor Optimism Eases Ahead Of Retail Earnings

By Lisa Levin
November 15, 6:34 AM
The CNN Money Fear and Greed index showed some easing in the overall market sentiment as US stocks dropped to start the week. The S&P 500 jumped around 5.9% last week, recording its best weekly surge since June.

AAP

Read More
1 minute read
  • Earnings
  • Markets
  • News
  • Pre-Market Outlook
  • Trading Ideas

Dow Dips Over 200 Points, Market Volatility Increases

By Lisa Levin
November 15, 5:35 AM
US stocks closed lower on Monday, as investors digested recent comments from the Federal Reserve officials. The S&P 500, during the previous week, recorded its biggest weekly percentage surge since late June.

AMZN

Read More
2 minute read
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Small Cap
  • Trading Ideas

Miniso Group, Monday.com And Other Big Gainers From Monday

By Lisa Levin
November 15, 3:34 AM
U.S. stocks closed lower on Monday, with the Dow Jones dropping more than 200 points. Here is the list of some big stocks recording gains in the previous session.

AGEN

Read More
1 minute read
  • Analyst Ratings
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Price Target
  • Small Cap

MacroGenics To Surge 138%? Plus This Analyst Sees $50 For Exact Sciences

By Lisa Levin
November 14, 11:48 AM
BMO Capital boosted the price target on MacroGenics, Inc. (NASDAQ: MGNX) from $5.7 to $16. BMO Capital analyst Etzer Darout upgraded the stock from Market Perform to Outperform. MacroGenics shares gained 3.5% to trade at $6.97 on Monday.

AIRS

Read More
2 minute read
  • Markets
  • Movers
  • News
  • Pre-Market Outlook
  • Small Cap
  • Trading Ideas

Unity Software, Amazon, Doximity And Other Big Gainers From Friday

By Lisa Levin
November 14, 6:28 AM
U.S. stocks closed higher on Friday, with the Nasdaq Composite jumping more than 200 points. Here is the list of some big stocks recording gains in the previous session.

AA

Read More
1 minute read
  • Earnings
  • Markets
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Trading Ideas

Tyson Foods, AECOM And 3 Stocks To Watch Heading Into Monday

By Lisa Levin
November 14, 5:29 AM
With US stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows:

ACM

Read More
1 minute read
  • Earnings
  • Markets
  • News
  • Pre-Market Outlook
  • Trading Ideas

Volatility In Markets Eases Further As US Stocks Extend Gains

By Lisa Levin
November 14, 5:11 AM
US stocks extended gains, with the S&P 500 and Nasdaq settling sharply higher on Friday. On Thursday, the S&P 500 and Nasdaq recorded their biggest daily percentage surge in over 2-1/2 years as annual inflation in the US dropped below the 8% mark for the first time in eight months.

AAPL

Posts pagination

Previous 1 … 458 459 460 … 538 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service